Clinician brochure · Sources
These are the sources behind the HLRCC Foundation clinician brochure (HLRCC at a Glance for Clinicians), which links here instead of printing a reference list. Numbers 1–11 follow the brochure's earlier printed reference list; 12–18 were added with the November 2026 edition (published diagnostic criteria, kidney MRI findings and surgery); 19–25 were added with v4.3 (fibroid percentages, Malayeri/NIH cyst MRI, metastasis and early detection).
HLRCC Foundation · hlrcc.org/clinician-references
Kamihara J, Schultz KAP, Rana HQ. FH tumor predisposition syndrome. In: GeneReviews®. University of Washington, Seattle; 2006 Jul 31 [updated 2025 May 8]. PMID 20301430.
GeneReviews chapter (opens in a new tab)PubMed 20301430 (opens in a new tab)
PDQ® Cancer Genetics Editorial Board. Hereditary leiomyomatosis and renal cell cancer (PDQ®): health professional version. National Cancer Institute; updated 2024 Nov 6. PMID 33724749.
PubMed 33724749 (opens in a new tab)NCI PDQ page (opens in a new tab)
Menko FH, Maher ER, Schmidt LS, et al. Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer. 2014;13(4):637-44. PMID 25012257.
PubMed 25012257 (opens in a new tab)DOI 10.1007/s10689-014-9735-2 (opens in a new tab)
Shuch B, Li S, Risch H, et al. Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer. Cancer. 2020;126(16):3657-66. PMID 32413184.
PubMed 32413184 (opens in a new tab)DOI 10.1002/cncr.32914 (opens in a new tab)
National Comprehensive Cancer Network. NCCN Guidelines for Patients®: Kidney Cancer, 2026 (based on NCCN Guidelines® for Kidney Cancer, Version 1.2026). nccn.org/patients
Michaeli O, Kim SY, Mitchell SG, et al. Update on cancer screening in children with syndromes of bone lesions, hereditary leiomyomatosis and renal cell carcinoma syndrome, and other rare syndromes. Clin Cancer Res. 2025;31(3):457-65. PMID 39601780.
PubMed 39601780 (opens in a new tab)PMC11790369 (opens in a new tab)
Kipnis LM, Breen KM, Koeller DR, et al. Germline and somatic fumarate hydratase testing in atypical uterine leiomyomata. Cancer Prev Res (Phila). 2024. PMID 38638033.
PubMed 38638033 (opens in a new tab)DOI 10.1158/1940-6207.CAPR-23-0535 (opens in a new tab)
Muller M, Guillaud-Bataille M, Salleron J, et al. Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration. Mod Pathol. 2018;31:974-83. PMID 29410489.
PubMed 29410489 (opens in a new tab)DOI 10.1038/s41379-018-0017-7 (opens in a new tab)
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the ACMG and the AMP. Genet Med. 2015;17(5):405-24. PMID 25741868.
PubMed 25741868 (opens in a new tab)DOI 10.1038/gim.2015.30 (opens in a new tab)
Deignan JL, Chung WK, Kearney HM, et al. Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the ACMG. Genet Med. 2019;21(6):1267-70. PMID 31015575.
PubMed 31015575 (opens in a new tab)DOI 10.1038/s41436-019-0478-1 (opens in a new tab)
Centers for Disease Control and Prevention. About cascade testing. cdc.gov/cascade-testing/about
Smit DL, Mensenkamp AR, Badeloe S, et al. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet. 2011;79(1):49-59. PMID 20618355.
PubMed 20618355 (opens in a new tab)DOI 10.1111/j.1399-0004.2010.01486.x (opens in a new tab)
Schmidt LS, Linehan WM. Hereditary leiomyomatosis and renal cell carcinoma. Int J Nephrol Renovasc Dis. 2014;7:253-60. PMID 25018647.
PubMed 25018647 (opens in a new tab)PMC4074185 (opens in a new tab)
Silverman SG, Pedrosa I, Ellis JH, et al. Bosniak classification of cystic renal masses, version 2019: an update proposal and needs assessment. Radiology. 2019;292:475-88. PMID 31210616.
PubMed 31210616 (opens in a new tab)PMC6677285 (opens in a new tab)
Sheikhy A, Zahergivar A, Golagha M, et al. Characterization of complex renal cysts in hereditary leiomyomatosis and renal cell cancer using magnetic resonance based qualitative features. Abdom Radiol (NY). 2026;51:1459-71. PMID 40952492.
PubMed 40952492 (opens in a new tab)PMC12971841 (opens in a new tab)
Gomella PT, Linehan WM, Ball MW. Precision surgery and kidney cancer: knowledge of genetic alterations influences surgical management. Genes (Basel). 2021;12(2):261. PMID 33670168.
PubMed 33670168 (opens in a new tab)PMC7916897 (opens in a new tab)
Bratslavsky G, Mendhiratta N, Daneshvar M, et al. Genetic risk assessment for hereditary renal cell carcinoma: clinical consensus statement. Cancer. 2021;127:3957-66. PMID 34343338.
PubMed 34343338 (opens in a new tab)PMC8711633 (opens in a new tab)
Hol JA, Jongmans MCJ, Littooij AS, et al. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature. Fam Cancer. 2020;19:55-63. PMID 31792767.
PubMed 31792767 (opens in a new tab)PMC7026215 (opens in a new tab)
Stewart L, Glenn GM, Stratton P, et al. Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer. Arch Dermatol. 2008;144(12):1584-92. PMID 19075141.
PubMed 19075141 (opens in a new tab)PMC2937541 (opens in a new tab)
Grubb RL 3rd, Franks ME, Toro J, et al. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol. 2007;177(6):2074-9. PMID 17509289.
PubMed 17509289 (opens in a new tab)DOI 10.1016/j.juro.2007.01.155 (opens in a new tab)
Forde C, et al. Hereditary leiomyomatosis and renal cell cancer: clinical, molecular, and screening features in a cohort of 185 affected individuals. Eur Urol Oncol. 2020;3(6):764-72. PMID 31831373.
PubMed 31831373 (opens in a new tab)DOI 10.1016/j.euo.2019.11.002 (opens in a new tab)
Paschall AK, Nikpanah M, Farhadi F, et al. Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome: spectrum of imaging findings. Clin Imaging. 2020;68:14-19. PMID 32562921.
PubMed 32562921 (opens in a new tab)PMC8916163 (opens in a new tab)
Chaurasia A, Gopal N, Dehghani Firouzabadi F, et al. Role of ultra-high b-value DWI in the imaging of hereditary leiomyomatosis and renal cell carcinoma (HLRCC). Abdom Radiol (NY). 2023. PMID 36207629.
PubMed 36207629 (opens in a new tab)PMC10681094 (opens in a new tab)
Schultz KAP, Rednam SP, et al. PTEN, DICER1, FH, and their associated tumor susceptibility syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res. 2017;23(12):e76-e82. PMID 28620008.
PubMed 28620008 (opens in a new tab)DOI 10.1158/1078-0432.CCR-17-0629 (opens in a new tab)
Toro JR, Nickerson ML, Wei MH, et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet. 2003;73(1):95-106. PMID 12772087.
PubMed 12772087 (opens in a new tab)DOI 10.1086/376435 (opens in a new tab)